rs11014204 - CACNB2
Magnitude 2.2 · 3 studies on file
Reported associations
-
Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program - Unknown journal (n.d.) · Unknown authors · PubMed 39024449
ABSTRACT: INTRODUCTION: Findings from genome-wide association studies (GWASs) have provided foundational knowledge of the genetic basis of disease, facilitating precision approaches for prevention and treatment. Current GWAS results are limited by underrepresentation of individuals from diverse populations, leading to concerns with generalizability regarding our knowledge of the relationships between genes, traits, and disease. The Department of Veterans Affairs (VA) Million Veteran Program (MVP), one of the largest US-based biobanks, addresses this need; 29% of MVP comprises individuals genetically similar to African (AFR), Admixed American (AMR), and East Asian (EAS) reference populations. With over 635,000 participants and more than 44.3M genotyped variants linked with detailed phenotyp
-
Insights from a Large-Scale Whole Genome Sequencing Study of Systolic Blood Pressure, Diastolic Blood Pressure, and Hypertension - Unknown journal (n.d.) · Unknown authors · PubMed 35652341
ABSTRACT: Background: The availability of whole genome sequencing data in large studies has enabled the assessment of coding and non-coding variants across the allele frequency spectrum for their associations with blood pressure. Methods: We conducted a multi-ancestry whole genome sequencing analysis of blood pressure among 51,456 Trans-Omics for Precision Medicine and Centers for Common Disease Genomics program participants (stage-1). Stage-2 analyses leveraged array data from UK Biobank (N=383,145), Million Veteran Program (N= 318,891), and Reasons for Geographic and Racial Differences in Stroke (N=10,643) participants, along with whole exome sequencing data from UK Biobank (N=199,631) participants. Results: Two blood pressure signals achieved genome-wide significance in meta-analyses of
-
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis - Unknown journal (n.d.) · Unknown authors · PubMed 32203549
ABSTRACT: Background Circulating lipoprotein lipids cause coronary heart disease (CHD). However, the precise way in which one or more lipoprotein lipid-related entities account for this relationship remains unclear. Using genetic instruments for lipoprotein lipid traits implemented through multivariable Mendelian randomisation (MR), we sought to compare their causal roles in the aetiology of CHD. Methods and findings We conducted a genome-wide association study (GWAS) of circulating non-fasted lipoprotein lipid traits in the UK Biobank (UKBB) for low-density lipoprotein (LDL) cholesterol, triglycerides, and apolipoprotein B to identify lipid-associated single nucleotide polymorphisms (SNPs). Using data from CARDIoGRAMplusC4D for CHD (consisting of 60,801 cases and 123,504 controls), we per
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
genetic hypertension risk Moderate
CACNB2 variant shows strong association with hypertension medication use and elevated systolic blood pressure in large cohorts
Screening
-
blood pressure monitoring Moderate
CACNB2 encodes voltage-gated calcium channel subunit; variant strongly associates with elevated systolic blood pressure
Check blood pressure at least annually